Network pharmacology examines flavonoids' effects on lung cancer, suggesting their potential for treatment.
Cassia-derived flavonoids represent promising multi-target candidates for lung cancer therapy, particularly through modulation of PTGS2, KIT, and XDH. Their favorable interaction profiles and safety predictions warrant further experimental and in vivo validation.
No takes yet. Share an insight, caveat, or question.
Shehri et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: